版本:
中国

BRIEF-Uniqure presents new preclinical data on AMT-130 in Huntington's disease

April 26 Uniqure NV

* Uniqure presents new preclinical data on AMT-130 in Huntington's disease

* One-Time administration of AMT-130 demonstrates for first time efficacy in large animal model

* Ind-Enabling toxicology study to commence in 2H 2017

* Uniqure NV - to commence toxicology study in non-human primates later this year, which co expects will support ind application for AMT-130 in 2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐